Cellular Senescence in Health, Disease, and Lens Aging
Pharmaceuticals · 12.02.2025 · 18 (2) · 244
DOI: 10.3390/ph18020244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 12.02.2025. Verfasst von Ying Qin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Cellular senescence is a state of irreversible cell cycle arrest that serves as a critical regulator of tissue homeostasis, aging, and disease. While transient senescence contributes to development, wound healing, and tumor suppression, chronic senescence drives inflammation, tissue dysfunction, and age-related pathologies, including cataracts. Lens epithelial cells (LECs), essential for maintaining lens transparency, are particularly vulnerable to oxidative stress-induced senescence, which accelerates lens aging and cataract formation. This review examines the dual role of senescence in LEC function and its implications for age-related cataractogenesis, alongside emerging senotherapeutic interventions.
Methods
This review synthesizes findings on the molecular mechanisms of senescence, focusing on oxidative stress, mitochondrial dysfunction, and the senescence-associated secretory phenotype (SASP). It explores evidence linking LEC senescence to cataract formation, highlighting key studies on stress responses, DNA damage, and antioxidant defense. Recent advances in senotherapeutics, including senolytics and senomorphics, are analyzed for their potential to mitigate LEC senescence and delay cataract progression.
Conclusions
LEC senescence is driven by oxidative damage, mitochondrial dysfunction, and impaired redox homeostasis. These factors activate senescence path-ways, including p53/p21 and p16/Rb, resulting in cell cycle arrest and SASP-mediated inflammation. The accumulation of senescent LECs reduces regenerative capacity, disrupts lens homeostasis, and contributes to cataractogenesis. Emerging senotherapeutics, such as dasatinib, quercetin, and metformin, show promise in reducing the senescent cell burden and modulating the SASP to preserve lens transparency.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
- North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
ORCID-Profile: Haoxin Liu
Förderung
- NEI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health (NIH)
Zitieren
APA
Qin, Y., Liu, H., & Wu, H. (2025). Cellular Senescence in Health, Disease, and Lens Aging. Pharmaceuticals, 18(2), 244. https://doi.org/10.3390/ph18020244
Vancouver
Qin Y, Liu H, Wu H. Cellular Senescence in Health, Disease, and Lens Aging. Pharmaceuticals. 2025;18(2):244. doi:10.3390/ph18020244
BibTeX
@article{Qin2025,
author = {Qin, Ying and Liu, Haoxin and Wu, Hongli},
title = {Cellular Senescence in Health, Disease, and Lens Aging},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {2},
pages = {244},
doi = {10.3390/ph18020244}
}
EUVIMED